Get the Stockscreener App
0.523
11.36%
-0.067
Pre-market:
.52
-0.003
-0.57%
Azitra Inc stock is traded at $0.523, with a volume of 3.35M.
It is down -11.36% in the last 24 hours and down -25.18% over the past month.
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
See More
Previous Close:
$0.59
Open:
$0.5332
24h Volume:
3.35M
Relative Volume:
0.71
Market Cap:
$1.84M
Revenue:
$1.27M
Net Income/Loss:
$-11.28M
P/E Ratio:
-0.0233
EPS:
-22.4496
Net Cash Flow:
$-10.46M
1W Performance:
-8.23%
1M Performance:
-25.18%
6M Performance:
+61.82%
1Y Performance:
+5.04%
1-Day Range:
$0.4963
$0.5591
1-Week Range:
$0.4668
$0.763
52-Week Range:
$0.1305
$1.40
Azitra Inc Stock (AZTR) Company Profile
Name
Azitra Inc
Sector
Industry
Phone
203 646 6446
Address
21 Business Park Drive, Branford
Compare AZTR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTR
Azitra Inc
|
0.523 | 3.19M | 1.27M | -11.28M | -10.46M | -22.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Azitra Inc Stock (AZTR) Latest News
Should I hold or sell Azitra Inc. stock in 20252025 Market Overview & Daily Oversold Bounce Ideas - newser.com
Understanding Azitra Inc.’s price movementInflation Watch & Fast Entry Momentum Alerts - newser.com
Is Azitra Inc. stock entering bullish territory2025 EndofYear Setup & Weekly Market Pulse Alerts - newser.com
Can Azitra Inc. hit a new high this monthMarket Growth Report & Reliable Price Action Trade Plans - newser.com
How Azitra Inc stock trades in high volatilityMarket Rally & High Accuracy Trade Signal Alerts - newser.com
How strong is Azitra Inc stock earnings growthJuly 2025 Highlights & High Accuracy Investment Entry Signals - newser.com
Can Azitra Inc stock attract ESG investments2025 Technical Overview & Technical Pattern Based Signals - newser.com
Is Azitra Inc. stock positioned well for digital economyJuly 2025 Pullbacks & Entry Point Strategy Guides - newser.com
Combining machine learning predictions for Azitra Inc.Sell Signal & High Yield Stock Recommendations - newser.com
Is a relief rally coming for Azitra Inc. holdersStop Loss & High Accuracy Trade Signal Alerts - newser.com
Is Azitra Inc. stock supported by strong fundamentalsWeekly Gains Summary & AI Optimized Trade Strategies - newser.com
Can Azitra Inc stock stage a strong rebound this quarterBuy Signal & Expert Curated Trade Ideas - newser.com
Why Azitra Inc stock stays on buy listsTrade Performance Summary & AI Enhanced Trading Alerts - newser.com
Azitra, Inc. (AZTR) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Azitra, Inc. (AZTR) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
What analysts say about Azitra Inc stockSwing Trading Watchlist & Set Your Capital Stop-Loss Limits Effectively - earlytimes.in
Ranking Azitra Inc. among high performing stocks via toolsTrade Performance Summary & Target Return Focused Stock Picks - newser.com
Azitra Inc Stock (AZTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Cap:
|
Volume (24h):